EVEN IN THE 21ST CENTURY, PEOPLE LIVING IN HARD-TO-REACH AREAS OF THE WORLD STILL STRUGGLE TO RECEIVE BASIC IMMUNIZATION.
ACCORDING TO THE WORLD HEALTH ORGANIZATION:
- 26 million children worldwide are not immunized, exposed to disabilities and premature death.
- 2.1 million people die each year from vaccine-preventable diseases.
- Strict vaccine refrigeration requirements contribute to vaccine wastage rates of 25% to 50% (small and large vials, respectively).
WE ARE DEVELOPING A NANOPARTICLE BASED CHEMICAL SHIELD THAT ALLOWS VACCINES TO SURVIVE WITHOUT REFRIGERATION. NANOLY'S TECHNOLOGY ENABLES CHEAP, EFFECTIVE, AND SAFE DELIVERY OF VACCINES TO ANYWHERE IN THE WORLD.
OUR BOTTOM LINE:
- CHEAP: decreased vaccine transportation and delivery cost to developing countries.
- EFFECTIVE: increased immunization access in remote areas of the world.
- SAFE: decreased vaccine spoilage and inventory waste and decreased carbon footprint.
ACCORDING TO THE WORLD HEALTH ORGANIZATION:
- 26 million children worldwide are not immunized, exposed to disabilities and premature death.
- 2.1 million people die each year from vaccine-preventable diseases.
- Strict vaccine refrigeration requirements contribute to vaccine wastage rates of 25% to 50% (small and large vials, respectively).
WE ARE DEVELOPING A NANOPARTICLE BASED CHEMICAL SHIELD THAT ALLOWS VACCINES TO SURVIVE WITHOUT REFRIGERATION. NANOLY'S TECHNOLOGY ENABLES CHEAP, EFFECTIVE, AND SAFE DELIVERY OF VACCINES TO ANYWHERE IN THE WORLD.
OUR BOTTOM LINE:
- CHEAP: decreased vaccine transportation and delivery cost to developing countries.
- EFFECTIVE: increased immunization access in remote areas of the world.
- SAFE: decreased vaccine spoilage and inventory waste and decreased carbon footprint.
